Celgene

Associate Director, Medical Scientist, US Medical Oncology, GU

Posted on: 15 Mar 2021

Princeton, NJ

Job Description

At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.

Position reports to the Director of US Medical Oncology, Genitourinary (GU). The primary responsibility of the Associate Director is developing and implementing the US Medical Strategies and objectives for assigned genitourinary tumors. This Associate Director role is responsible for integrating and aligning GU strategies through establishing and maintaining cross-functional collaborative relationships with key stakeholders including, but not limited to, US Commercialization, WW Medical, Clinical Development, Medical Capabilities teams, etc.

Key Responsibilities

* Provide strategic, scientific and executional leadership while partnering with the integrated matrix team, including Medical, Commercial and Access organizations

* Develop/refine and implement key medical activities, including medical advisory boards, Field Medical Scientist resources and training, congresses, reactive content, and communication strategy, including publications

* Partner with US Commercial and Access organizations to integrate medical perspectives into the commercial strategy and ensure appropriate alignment between commercial and medical activities

* Develop and maintain long-term, trusted relationships with external thought leaders and scientific experts to assess unmet medical needs in order to develop an appropriate medical strategy

* Interacts and maintains relationships with the medical matrix (particularly Field Medical, Worldwide Medical, and Medical Capabilities), physician leaders and researchers, Competitive Intelligence, Payers and Advocacy groups and other external and internal customers to implement the US disease strategy

* Collaborates with functional areas outside of medical including marketing, sales, access, legal, regulatory, clinical operations, and research and development

* Ensure US medical strategies, objectives and tactics are aligned across the medical matrix and integrated with the strategic brand plan

Qualifications & Experience

* Advanced scientific degree (MD, PhD, PharmD, DNP)

* Prior (3-5+ years) pharmaceutical industry experience in medical affairs is preferred

* Highly organized and motivated individual with the ability to lead multiple projects and initiatives across diverse high performing matrix teams

* Possess excellent communication and presentation skills, both verbal and written

* He or she should have an understanding of pharmaceutical drug development, including clinical development, regulatory, life cycle management of pharmaceutical products, and collaboration with Thought Leaders in the field

* The ideal candidate will have clinical expertise, and/or some relevant experience in the disease area within the pharmaceutical industry, such as within Medical Affairs or Clinical Development

* Must have strong interpersonal and communication skills to navigate complex situations and gain alignment with diverse stakeholders, and work effectively within cross-functional teams

* Demonstrated ability to execute and deliver results in a deadline-driven environment while managing multiple priorities

* Estimated 20% travel (as applicable)

Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

Our company is committed to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an approval of accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or any part of the recruitment process direct your inquiries to adastaffingsupport@bms.com. Visit careers.bms.com/eeo-accessibility to access our complete Equal Employment Opportunity statement.

Celgene

Summit, NJ

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.

The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.

The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.